Study in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance to Enzalutamide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Multicenter Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer to Identify Mechanisms Driving Resistance
Clin. Cancer Res 2021 Apr 13;[EPub Ahead of Print], RR McKay, L Kwak, J Crowdis, JM Sperger, SG Zhao, W Xie, L Werner, RT Lis, Z Zhang, XX Wei, JM Lang, EM Van Allen, RS Bhatt, EY Yu, PS Nelson, GJ Bubley, B Montgomery, ME TaplinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.